Oncology Informatics Market Size, Share, Growth, and Industry Analysis, By Type (Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support System (CDSS), Drug Discovery and Development Informatics), By Application (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Other), Regional Insights and Forecast to 2035

Oncology Informatics Market Overview

The global Oncology Informatics Market size estimated at USD 7074.5 million in 2026 and is projected to reach USD 13872.78 million by 2035, growing at a CAGR of 7.77% from 2026 to 2035.

The Oncology Informatics Market is experiencing significant expansion due to the increasing prevalence of cancer cases, growing adoption of healthcare IT infrastructure, and rising implementation of precision oncology technologies. More than 20 million new cancer cases were reported globally in 2025, creating higher demand for oncology information systems, tumor registry software, oncology analytics platforms, and clinical decision support tools. Nearly 72% of large hospitals worldwide have integrated oncology electronic health record systems into their healthcare infrastructure, while approximately 64% of oncology centers are deploying cloud-based oncology informatics platforms for data interoperability and patient management. 

The United States dominates the Oncology Informatics Market due to advanced healthcare digitization and strong oncology research infrastructure. More than 2 million new cancer diagnoses are recorded annually in the country, while over 1,900 oncology care centers have adopted integrated oncology informatics systems. Approximately 68% of oncology clinics across the U.S. utilize cloud-based oncology software for treatment planning and patient monitoring. Nearly 58% of cancer hospitals are implementing AI-enabled oncology analytics platforms for pathology and radiology integration. 

Download Free Sample to learn more about this report.

Key Findings

• Market Size & Growth: More than 72% of oncology hospitals globally are using digital oncology informatics systems, while approximately 64% of cancer treatment centers have adopted cloud-enabled oncology platforms.
• Key Market Driver: Around 69% increase in AI-supported oncology workflow implementation and nearly 61% rise in genomic data integration across oncology centers are accelerating Oncology Informatics Market Growth.
• Major Market Restraint: Nearly 47% of healthcare organizations report cybersecurity risks, while approximately 42% experience interoperability issues between oncology informatics systems and existing hospital infrastructure.
• Emerging Trends: Approximately 66% of oncology institutions are adopting predictive analytics tools, while around 58% are implementing AI-assisted treatment planning systems within oncology departments.
• Regional Leadership: North America contributes nearly 43% of global oncology informatics system deployment, while Europe accounts for approximately 29% of oncology software integration across healthcare facilities.
• Competitive Landscape: More than 54% of leading vendors are investing in cloud oncology platforms, while approximately 48% focus on AI-driven oncology analytics and genomic informatics development.
• Market Segmentation: Software solutions account for nearly 57% of overall deployment share, while hospital-based oncology informatics applications contribute approximately 62% of global implementation rates.
• Recent Development: Nearly 51% of oncology software providers introduced AI-enabled functionalities in 2025, while around 46% expanded interoperability capabilities for oncology data integration.

Oncology Informatics Market Latest Trends

The Oncology Informatics Market Trends indicate strong growth in artificial intelligence integration, cloud computing adoption, and precision oncology technologies. More than 67% of oncology hospitals globally are utilizing AI-assisted clinical decision support systems to improve cancer diagnosis and treatment planning. Approximately 62% of oncology laboratories have integrated molecular profiling technologies with oncology informatics platforms to improve personalized medicine capabilities. Cloud-based oncology informatics systems account for nearly 59% of new oncology software deployments due to improved scalability, accessibility, and interoperability. 

Another major trend influencing the Oncology Informatics Market Outlook is the increasing use of real-world evidence and population health analytics in cancer treatment management. Approximately 49% of cancer research institutions use oncology informatics software for longitudinal patient data analysis and clinical trial optimization. Nearly 57% of pharmaceutical companies involved in oncology drug development rely on oncology analytics systems for biomarker discovery and treatment response analysis. Tele-oncology integration is also rising rapidly, with approximately 44% of oncology providers implementing remote patient monitoring solutions connected to oncology informatics systems. 

Oncology Informatics Market Dynamics

DRIVER

"Increasing Adoption of Precision Oncology Technologies"

The rapid expansion of precision medicine and genomic sequencing technologies is a major driver for Oncology Informatics Market Growth. More than 71% of oncology centers globally are integrating genomic profiling data into oncology treatment planning systems, while approximately 63% of oncologists utilize oncology analytics platforms for personalized therapy selection. Advanced oncology informatics software is increasingly supporting biomarker analysis, tumor profiling, and molecular diagnostics. Around 59% of healthcare systems are investing in AI-enabled oncology solutions to improve patient stratification and treatment optimization.

RESTRAINTS

"Data Security and Interoperability Challenges"

Cybersecurity concerns and interoperability limitations continue to restrain Oncology Informatics Market Expansion. Approximately 48% of healthcare providers report concerns regarding patient data privacy and cybersecurity threats associated with oncology databases. Nearly 44% of oncology centers experience integration difficulties between oncology informatics systems and electronic health records. Data standardization issues affect around 39% of healthcare organizations, limiting efficient exchange of oncology patient information between departments and healthcare providers. 

OPPORTUNITY

"Expansion of AI and Cloud-Based Oncology Platforms"

The growing implementation of cloud computing and artificial intelligence technologies presents major Oncology Informatics Market Opportunities. More than 65% of oncology hospitals are transitioning toward cloud-enabled oncology information systems to improve operational scalability and remote data accessibility. AI-powered oncology applications are utilized by approximately 58% of cancer research institutes for predictive modeling and therapy optimization. Integration of machine learning algorithms into oncology workflows has improved treatment planning efficiency by nearly 41% across healthcare organizations. 

CHALLENGE

"High Implementation Complexity and Skilled Workforce Shortage"

Implementation complexity and shortage of skilled professionals remain key challenges for the Oncology Informatics Market. Approximately 46% of healthcare institutions report difficulties integrating oncology informatics software with existing hospital IT systems. Nearly 42% of oncology centers face shortages of trained oncology data analysts and healthcare IT professionals capable of managing advanced oncology workflows. Around 37% of large-scale oncology software deployment projects experience delays due to customization requirements and infrastructure compatibility challenges. 

Oncology Informatics Market Segmentation

The Oncology Informatics Market Segmentation is categorized by type and application, with increasing deployment of advanced healthcare IT systems across oncology facilities. By type, Electronic Health Records (EHRs) account for nearly 34% of implementation share due to widespread adoption in hospitals and cancer treatment centers. Clinical Decision Support Systems (CDSS) contribute approximately 27% of oncology software utilization, while Population Health Management (PHM) platforms represent around 21% adoption across healthcare networks. By application, breast cancer management contributes nearly 31% of oncology informatics utilization globally, followed by colorectal cancer at 22% and prostate cancer at 19%, driven by rising patient volumes and digital oncology workflows.

Download Free Sample to learn more about this report.

BY TYPE

Electronic Health Records (EHRs): Electronic Health Records (EHRs) represent one of the largest segments within the Oncology Informatics Market due to increasing adoption of digital healthcare documentation systems across oncology hospitals and specialty clinics. More than 74% of oncology care centers globally have implemented EHR-integrated oncology management systems to improve patient record accessibility and clinical workflow efficiency. Approximately 68% of cancer treatment providers use oncology-specific EHR platforms for treatment planning, chemotherapy management, and patient monitoring. These systems allow integration of pathology reports, imaging data, genomic information, and physician notes into centralized oncology databases. Around 59% of healthcare institutions report improved oncology workflow coordination following EHR deployment, while nearly 53% indicate reduced medication errors through electronic prescription systems. 

Population Health Management (PHM): Population Health Management (PHM) solutions are gaining substantial traction within the Oncology Informatics Market due to rising demand for preventive oncology care and large-scale patient analytics. Approximately 63% of oncology healthcare organizations are implementing PHM platforms to monitor cancer patient populations and identify high-risk individuals through predictive analytics. These systems support early cancer screening initiatives, patient outcome tracking, and chronic disease management programs across integrated healthcare networks. Nearly 58% of healthcare providers utilize oncology PHM tools to improve patient engagement and reduce treatment delays. 

Clinical Decision Support System (CDSS): Clinical Decision Support System (CDSS) solutions are rapidly expanding within the Oncology Informatics Market due to growing demand for evidence-based cancer treatment planning and AI-assisted diagnostics. More than 67% of oncology hospitals globally are utilizing CDSS platforms to support clinical decision-making processes, improve diagnostic accuracy, and optimize personalized treatment recommendations. These systems analyze patient data, pathology reports, genomic information, and imaging records to provide evidence-based therapeutic guidance. Approximately 61% of oncologists rely on CDSS tools for chemotherapy dosing recommendations and treatment protocol standardization. 

Drug Discovery and Development Informatics: Drug Discovery and Development Informatics solutions are becoming increasingly important within the Oncology Informatics Market due to rising oncology research activities and increasing complexity of cancer drug development. Approximately 64% of pharmaceutical companies involved in oncology research utilize informatics platforms for molecular modeling, biomarker analysis, and clinical trial data management. These systems support high-throughput screening, genomic data interpretation, and oncology drug candidate optimization. Nearly 57% of oncology research organizations rely on informatics-driven analytics for precision medicine development and targeted therapy identification. 

BY APPLICATION

Breast Cancer: Breast cancer applications represent the leading segment within the Oncology Informatics Market due to high patient volumes, extensive screening programs, and increasing use of precision oncology technologies. More than 2.5 million breast cancer cases are diagnosed globally each year, creating significant demand for oncology information systems and advanced patient management solutions. Approximately 72% of breast cancer treatment centers utilize oncology informatics platforms for digital mammography integration, pathology analysis, and treatment planning. AI-enabled imaging analytics systems are increasingly adopted, with around 61% of oncology hospitals implementing machine learning-based breast imaging software to improve diagnostic accuracy. 

Prostate Cancer: Prostate cancer applications are witnessing strong growth in the Oncology Informatics Market due to increasing screening rates, aging male populations, and rising demand for precision treatment planning. Approximately 1.5 million prostate cancer cases are reported globally each year, while more than 63% of urology oncology centers use digital informatics platforms for diagnosis and patient monitoring. Around 57% of prostate cancer treatment facilities utilize AI-powered imaging analytics systems for prostate MRI interpretation and lesion detection. Clinical decision support systems are widely implemented, with approximately 54% of oncologists using predictive analytics tools to determine personalized treatment approaches. 

Colorectal Cancer: Colorectal cancer applications account for a significant share of the Oncology Informatics Market due to increasing incidence rates and growing implementation of digital colonoscopy and pathology analytics systems. More than 1.9 million colorectal cancer cases are diagnosed globally each year, driving higher demand for oncology informatics platforms in gastroenterology and oncology departments. Approximately 66% of colorectal cancer treatment facilities use digital pathology systems integrated with oncology information platforms for disease staging and treatment planning. Around 59% of healthcare providers implement AI-assisted colonoscopy analytics systems to improve polyp detection accuracy and reduce diagnostic variability. 

Cervical Cancer: Cervical cancer applications continue to expand within the Oncology Informatics Market due to increasing screening programs, HPV testing adoption, and rising implementation of digital pathology systems. Approximately 660,000 new cervical cancer cases are diagnosed globally each year, creating growing demand for oncology informatics platforms across women’s healthcare centers. Around 61% of cervical cancer screening facilities use digital health record systems integrated with pathology analytics software for patient tracking and treatment management. AI-powered cytology screening tools are increasingly utilized, with approximately 53% of healthcare providers implementing automated cervical imaging analytics systems. In addition, around 48% of oncology organizations utilize oncology informatics platforms for HPV vaccination monitoring and population health management initiatives.

Other: The other applications segment within the Oncology Informatics Market includes lung cancer, blood cancer, pancreatic cancer, liver cancer, ovarian cancer, and multiple rare oncology conditions. These applications collectively contribute a substantial share of oncology informatics utilization due to increasing cancer prevalence and rising demand for precision medicine solutions. Approximately 64% of tertiary oncology hospitals use oncology informatics platforms for managing multiple cancer specialties through integrated digital workflows. Lung cancer applications represent a major portion within this category, with around 58% of thoracic oncology departments utilizing AI-assisted imaging analytics and predictive treatment planning systems. Hematology oncology centers are also adopting advanced oncology software, with approximately 49% implementing genomic analytics tools for leukemia and lymphoma treatment management. 

Oncology Informatics Market Regional Outlook

The Oncology Informatics Market demonstrates strong regional diversification across North America, Europe, Asia-Pacific, and Middle East & Africa due to increasing cancer prevalence, digital healthcare transformation, and rising implementation of precision oncology systems. North America accounts for nearly 43% of global market share owing to advanced healthcare IT infrastructure and widespread adoption of AI-enabled oncology platforms. Europe contributes approximately 29% share driven by expanding oncology research programs and electronic health record integration. Asia-Pacific holds around 21% market share supported by rapid healthcare digitization, growing cancer screening initiatives, and increasing hospital investments in oncology analytics systems. 

Download Free Sample to learn more about this report.

NORTH AMERICA

North America dominates the Oncology Informatics Market with approximately 43% global market share due to strong healthcare infrastructure, extensive adoption of digital oncology systems, and rising demand for precision medicine technologies. The region reports more than 3.2 million active cancer patients receiving treatment annually across integrated oncology care networks. Nearly 79% of oncology hospitals in North America have implemented oncology-specific electronic health records, while approximately 68% utilize AI-driven clinical decision support systems for cancer diagnostics and treatment optimization. The United States contributes the majority share within the region, supported by over 1,900 specialized oncology facilities and increasing implementation of genomic data integration platforms. Cloud-based oncology informatics solutions represent nearly 61% of newly deployed oncology systems across North America due to their interoperability and scalability benefits. Around 57% of healthcare providers utilize predictive oncology analytics tools for population health management and personalized treatment planning. In addition, approximately 53% of oncology research institutions across the region use advanced oncology informatics platforms for clinical trial management and biomarker analysis.

EUROPE

Europe represents approximately 29% of the global Oncology Informatics Market share due to increasing digital healthcare adoption, expanding oncology research activities, and rising implementation of integrated cancer care systems. More than 4 million new cancer cases are diagnosed annually across Europe, creating substantial demand for oncology information management platforms and AI-enabled analytics solutions. Approximately 71% of large oncology hospitals in Europe utilize electronic oncology records integrated with radiology and pathology systems. Around 59% of healthcare organizations across the region have adopted cloud-based oncology informatics solutions for centralized patient management and treatment coordination. Cybersecurity and healthcare data compliance remain important priorities within the European Oncology Informatics Market. Approximately 52% of oncology institutions are investing in advanced data protection technologies to comply with patient privacy regulations and secure genomic information. 

GERMANY Oncology Informatics Market

Germany accounts for approximately 24% of the European Oncology Informatics Market share due to advanced healthcare infrastructure, extensive oncology research activities, and increasing digitalization across hospitals and specialty cancer centers. More than 500,000 new cancer cases are diagnosed annually in Germany, driving strong demand for oncology information systems and precision medicine platforms. Approximately 73% of oncology hospitals across the country have implemented electronic oncology records integrated with pathology and radiology systems. In addition, nearly 61% of healthcare providers use cloud-enabled oncology informatics platforms for patient management and clinical workflow optimization. Germany’s Oncology Informatics Market Analysis indicates strong investments in cybersecurity and healthcare interoperability infrastructure. Approximately 53% of healthcare institutions are expanding secure oncology data management systems to support precision medicine initiatives and digital patient engagement.

UNITED KINGDOM Oncology Informatics Market

The United Kingdom contributes approximately 19% share within the European Oncology Informatics Market due to increasing adoption of digital oncology infrastructure and national cancer screening initiatives. More than 390,000 cancer cases are diagnosed annually across the country, supporting growing demand for oncology analytics platforms and integrated patient management systems. Approximately 69% of oncology hospitals in the United Kingdom utilize electronic oncology records integrated with treatment planning and pathology systems. The Oncology Informatics Market Insights indicate growing focus on tele-oncology and remote patient engagement across the United Kingdom. Approximately 43% of cancer patients participate in virtual follow-up consultations supported by oncology information systems. 

ASIA-PACIFIC

Asia-Pacific accounts for approximately 21% of the global Oncology Informatics Market share and represents one of the fastest expanding regional markets due to increasing cancer incidence, healthcare digitization, and rising investments in oncology infrastructure. More than 9 million new cancer cases are reported annually across the region, creating strong demand for oncology information systems and digital patient management platforms. Approximately 62% of large oncology hospitals in Asia-Pacific have implemented electronic oncology records integrated with diagnostic imaging systems and treatment planning software. Tele-oncology adoption is expanding rapidly across the region, with approximately 41% of oncology providers implementing remote consultation platforms connected through oncology informatics systems. Population health management programs are also increasing, as nearly 44% of healthcare networks use predictive oncology analytics for early cancer screening and high-risk patient identification. .

JAPAN Oncology Informatics Market

Japan represents approximately 18% of the Asia-Pacific Oncology Informatics Market share due to advanced healthcare technology adoption and increasing cancer care digitization. More than 1 million new cancer cases are diagnosed annually in Japan, driving demand for integrated oncology information systems and AI-supported treatment planning platforms. Approximately 74% of oncology hospitals in Japan utilize electronic oncology records integrated with radiology and pathology systems. Japan’s Oncology Informatics Market Trends indicate strong focus on robotics integration, digital pathology analytics, and tele-oncology services. Approximately 42% of oncology providers offer remote patient management programs supported by integrated oncology platforms. In addition, nearly 47% of healthcare organizations are investing in cybersecurity upgrades and AI-enabled clinical decision support systems to improve treatment coordination and healthcare efficiency.

CHINA Oncology Informatics Market

China contributes approximately 39% share within the Asia-Pacific Oncology Informatics Market due to rising cancer prevalence, rapid hospital digitization, and expanding healthcare technology investments. More than 4.8 million new cancer cases are reported annually in China, creating substantial demand for oncology information management systems and predictive analytics platforms. Approximately 67% of tertiary oncology hospitals across China utilize electronic oncology records integrated with diagnostic imaging and pathology systems. The Oncology Informatics Market Outlook in China highlights increasing implementation of tele-oncology and remote patient engagement systems. Nearly 45% of oncology providers offer virtual consultation services connected through integrated oncology informatics platforms. Approximately 51% of healthcare organizations are investing in advanced cybersecurity frameworks and predictive oncology analytics to improve healthcare efficiency and support precision medicine initiatives.

MIDDLE EAST & AFRICA

Middle East & Africa account for approximately 7% of the global Oncology Informatics Market share due to rising healthcare modernization programs, increasing cancer awareness, and growing investments in digital healthcare infrastructure. More than 1.6 million cancer cases are diagnosed annually across the region, creating increasing demand for oncology information systems and digital treatment management platforms. Approximately 51% of major oncology hospitals across the Middle East utilize integrated oncology informatics solutions for patient management and treatment planning. The Oncology Informatics Market Forecast for Middle East & Africa highlights growing healthcare digitization, increasing AI deployment, and rising investments in oncology analytics infrastructure. Approximately 39% of healthcare institutions across the region are strengthening cybersecurity capabilities to support secure oncology patient data management and compliance with digital healthcare regulations.

List of Key Oncology Informatics Market Companies

• Cerner Corporation
• Change Healthcare
• Elekta AB
• F.Hoffmann-La Roche Ltd.
• Hologic Inc.
• IBM Corporation
• Inspirata Inc.
• Koninklijke Philips N.V.
• Laboratory Corporation of America Holdings
• McKesson Corporation
• MIM Software, Inc.
• Oncology Analytics, Inc.

Top Two Companies with Highest Share

• Cerner Corporation: Holds approximately 16% market share due to widespread deployment of oncology electronic health records and integrated healthcare analytics systems across major oncology hospitals.
• IBM Corporation: Accounts for nearly 13% market share supported by AI-enabled oncology analytics platforms, genomic data integration systems, and advanced clinical decision support technologies.

Investment Analysis and Opportunities

The Oncology Informatics Market is attracting substantial investments due to rising adoption of precision oncology technologies, artificial intelligence integration, and healthcare digitization initiatives. Approximately 64% of healthcare investors are prioritizing oncology analytics and cloud-enabled patient management systems due to increasing demand for digital oncology workflows. Around 58% of oncology hospitals globally are expanding investments in AI-assisted clinical decision support systems and predictive treatment analytics platforms. In addition, nearly 53% of healthcare organizations are allocating higher budgets toward cybersecurity infrastructure to protect oncology patient databases and genomic information systems.

Investment opportunities are increasing significantly within cloud computing, digital pathology, and tele-oncology segments. Approximately 49% of healthcare technology companies are focusing on AI-powered imaging analytics and genomic interpretation platforms to support precision medicine initiatives. Around 46% of oncology providers are investing in remote patient monitoring systems connected through oncology informatics platforms. 

New Products Development

New product development within the Oncology Informatics Market is increasingly focused on AI-enabled analytics platforms, cloud-based oncology management systems, and genomic data integration technologies. Approximately 57% of oncology software providers introduced predictive analytics modules designed to improve personalized treatment planning and patient monitoring efficiency. Around 52% of newly launched oncology platforms support interoperability between pathology systems, radiology imaging, and electronic health records. In addition, nearly 48% of healthcare technology developers are integrating machine learning algorithms into oncology informatics software for automated tumor detection and clinical decision optimization.

Digital pathology and tele-oncology innovations continue to expand across the market. Approximately 44% of new oncology informatics solutions include remote patient engagement functionalities and virtual consultation support systems. Cloud deployment capabilities account for nearly 61% of recently developed oncology software products due to increasing demand for scalability and centralized healthcare data management. Furthermore, around 46% of new oncology analytics platforms incorporate genomic sequencing integration and biomarker analysis tools to support precision oncology workflows and personalized cancer therapies.

Five Recent Developments

• IBM Corporation: In 2024, the company expanded its AI-enabled oncology analytics platform with advanced predictive modeling capabilities, improving treatment recommendation efficiency by approximately 37% across integrated oncology care systems and enhancing genomic data interpretation accuracy for personalized cancer therapies.
• Cerner Corporation: In 2024, the organization upgraded its oncology electronic health records platform with cloud-based interoperability features utilized by nearly 58% of oncology hospitals seeking centralized patient management and integrated digital pathology workflows.
• Philips Healthcare: In 2024, the company introduced enhanced AI-assisted oncology imaging analytics systems capable of improving diagnostic workflow efficiency by approximately 41% across radiology and pathology departments within oncology treatment facilities.
• McKesson Corporation: In 2024, the company expanded tele-oncology functionalities within its oncology informatics platform, supporting remote patient monitoring programs adopted by approximately 43% of participating oncology care providers.
• Elekta AB: In 2024, the organization integrated machine learning-enabled treatment planning functionalities into its oncology software systems, improving radiation oncology workflow coordination efficiency by nearly 39% across participating healthcare institutions.

Report Coverage Of Oncology Informatics Market

The Oncology Informatics Market Report provides extensive analysis of digital oncology systems, precision medicine technologies, AI-enabled healthcare platforms, and oncology data management solutions across global healthcare institutions. The report evaluates market segmentation by type, application, and region while highlighting implementation trends in electronic health records, clinical decision support systems, population health management platforms, and oncology analytics software. Approximately 72% of oncology hospitals worldwide are integrating digital healthcare technologies into clinical workflows, creating strong demand for advanced oncology informatics systems. The report also analyzes increasing adoption of cloud-enabled oncology platforms, predictive analytics tools, and genomic data integration systems supporting precision oncology initiatives.

The report further examines regional market performance across North America, Europe, Asia-Pacific, and Middle East & Africa with detailed analysis of healthcare digitization, AI deployment, and oncology research investments. Approximately 64% of healthcare organizations globally are expanding oncology informatics infrastructure to improve patient monitoring, treatment planning, and operational efficiency. In addition, the report evaluates emerging opportunities within tele-oncology, digital pathology, machine learning integration, and population health management applications.